Alan Bernstein | |
---|---|
Born | [1] | June 25, 1947
Alma mater | University of Toronto |
Known for | Health research Science policy Mentorship Leadership |
Awards | FRSC (1991) The McLaughlin Medal, The Royal Society of Canada (1996) The Genetics Society of Canada Award of Excellence (1998) Officer, Order of Canada (2002) Gairdner Wightman Award 2008) Canadian Medical Hall of Fame (2015) Order of Ontario (2017) Companion, Order of Canada (2023) |
Scientific career | |
Institutions | University of Oxford Canadian Institute for Advanced Research Canadian Institutes of Health Research Global HIV Vaccine Enterprise Imperial Cancer Research Fund Mount Sinai Hospital, Toronto Ontario Cancer Institute |
Thesis | A Genetic Analysis of the TOL(A,B) Locus of Escherichia Coli K-12 (1972) |
Doctoral advisor | James Till |
Alan Bernstein CC OOnt FRSC (born June 25, 1947) is Professor Emeritus at the University of Toronto and President Emeritus of the Canadian Institute for Advanced Research (CIFAR), where he served as President and CEO from 2012 to 2022. A Distinguished Fellow at the Munk School of Global Affairs and Public Policy, he is also a Fellow and Member of the Standing Committee for Science Planning at the International Science Council (2022-2025). Canadian Bernstein is recognized as a leader in health research, science policy, mentorship and organizational leadership.
Born in Toronto, Bernstein attended Oakwood Collegiate Institute, [2] and then received his BSc. (Honours) and the James Loudon Gold Medal in Mathematics and Physics from the University of Toronto in 1968. [3] He pursued biomedical research and obtained his Ph.D. at the University of Toronto in 1972 under the supervision of James Till with a thesis focusing on a genetic analysis of membrane mutants Escherichia coli . [4]
Following his PhD, Bernstein undertook postdoctoral research with Dr G Steven Martin in London at the Imperial Cancer Research Fund, where he began working on retroviruses and their oncogenes. [5]
Bernstein returned to Canada in 1974 to join the faculty of the Ontario Cancer Institute. In 1985, he joined the new Samuel Lunenfeld Research Institute at Mount Sinai Hospital as Head of the Division of Molecular and Developmental Biology, and then served as its director of research from 1994 to 2000. [6]
In 2000, Bernstein became the inaugural president of the Canadian Institutes of Health Research (CIHR), where he oversaw the transformation of health research in Canada and championed women, early career scientists, and the importance of interdisciplinary team research. [7]
In 2007, he became the first executive director of the Global HIV Vaccine Enterprise, an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine. [5] As executive director, Bernstein oversaw the enterprise and led the development of the 2010 Scientific Strategic Plan for HIV vaccine development. [8]
In 2012, Bernstein joined CIFAR as president and CEO, where he was responsible for developing and leading the Institute's overall strategic direction. Under his presidency, the organization launched two Global Calls for Ideas [9] and the CIFAR Azrieli Global Scholars program for early career investigators, as well as expanding the delivery of knowledge mobilization and public engagement activities, [10] and moving in to offices in the MaRS Discovery District. [11] It was during his leadership that the Government of Canada asked CIFAR to develop and lead the Pan-Canadian Artificial Intelligence Strategy. [12] Upon his departure from CIFAR, a $1 million scholarship fund was created by donors in his name for select CIFAR Azrieli Global Scholars who become CIFAR Fellows. [13]
In 2023, Bernstein was appointed Professor and Director of Global Health at the University of Oxford where he oversees a new interdisciplinary, cross-University initiative in all aspects of global health.
Bernstein continues to be an active member of many advisory and review boards in Canada, the U.S., U.K., Italy, and Australia, including the Bill & Melinda Gates Foundation, [14] the McGill University Health Centre [15] and the Cumming School of Medicine, Calgary. He also served as co-chair of the Scientific Advisory Committee for Stand Up to Cancer Canada with Phillip A. Sharp.
Bernstein is a vocal advocate for interdisciplinary research, early-career investigators, and intellectual freedom. [16] [17] In his public remarks, he often emphasizes the importance of early-career researchers and diversity in science. [18] [19]
Bernstein's research interests have centered on blood cell formation (hematopoiesis), cancer and embryonic development. He has authored more than 225 peer-reviewed scientific publications.
For his contributions to science in Canada, and internationally, Bernstein has received numerous awards, including:
He is also the recipient of honorary degrees from Dalhousie University (2007), [32] the University of British Columbia (2009), [33] the University of Ottawa (2009), [34] McGill University (2010), [35] Queen's University (2013), [36] the University of Sherbrooke (2014), [37] the University of Toronto (2019), [38] and Western University (2019). [39]
The Royal Society of Canada, also known as the Academies of Arts, Humanities, and Sciences of Canada, is the senior national, bilingual council of distinguished Canadian scholars, humanists, scientists, and artists. The primary objective of the RSC is to promote learning and research in the arts, the humanities, and the sciences. The RSC is Canada's national academy and exists to promote Canadian research and scholarly accomplishment in both official languages; to recognize academic and artistic excellence; and to advise governments, non-governmental organizations, and Canadians on matters of public interest.
James Jude Orbinski is a Canadian physician, humanitarian activist, author, and scholar in global health. Dr. Orbinski began his role as principal of Massey College at the University of Toronto in the 2024-2025 academic year, where he is also Full Professor in the Department of Family and Community Medicine in the Temerty Faculty of Medicine, and is cross-appointed to the Munk School of Global Affairs and Public Policy, as well as the Dalla Lana School of Public Health,. Previously a professor in the Faculty of Health Science at York University, Dr. Orbinski founded the Dahdaleh Institute of Global Health Research.
Sir Peter Karel, Baron Piot is a Belgian-British microbiologist known for his research into Ebola and AIDS.
Phil Gold is a Canadian physician, scientist, professor and author.
Joseph Louis Rotman was a Canadian businessman and philanthropist. Rotman was the founder, benefactor and member of organizations such as the Clairvest Group Inc., the Rotman Research Institute, the Rotman School of Management, and the Rotman Institute of Philosophy. Throughout his life, he received three honorary degrees, as well as an induction into the Canadian Business Hall of Fame. He is well-regarded for donating his time and financial assistance to numerous philanthropic causes including the arts, education and healthcare.
The Canadian Institutes of Health Research is a federal agency responsible for funding health and medical research in Canada. Comprising 13 institutes, it is the successor to the Medical Research Council of Canada.
Stephen John Toope is a Canadian legal scholar, academic administrator and a scholar specializing in human rights, public international law and international relations. In November 2022, he was appointed as the fifth president and CEO of the Canadian Institute for Advanced Research (CIFAR). Prior to this, he served for five years as the 346th Vice-Chancellor of the University of Cambridge.
The Canadian Institute for Advanced Research (CIFAR) is a Canadian-based global research organization that brings together teams of top researchers from around the world to address important and complex questions. It was founded in 1982 and is supported by individuals, foundations and corporations, as well as funding from the Government of Canada and the provinces of Alberta and Quebec.
Lorne Allan Babiuk, is a Canadian scientist specializing in immunology, pathogenesis, virology, molecular virology, and vaccinology. He is the Vice-President of Research at the University of Alberta and the former Director of the Vaccine and Infectious Disease Organization at the University of Saskatchewan. Dr Babiuk holds the Canada Research Chair in Vaccinology and Biotechnology and is Chair of the Board for Pan-Provincial Vaccine Enterprise (PREVENT), a vaccine development company.
Victor Joseph Dzau is a Chinese-American doctor and academic. He serves as the President of the United States National Academy of Medicine of the United States National Academy of Sciences and Vice Chair of its National Research Council. He is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and former president and chief executive officer of Duke University Medical Center.
Michael R. Hayden, is a Killam Professor of Medical Genetics at the University of British Columbia, the highest honour UBC can confer on any faculty member. Only four such awards have ever been conferred in the Faculty of Medicine. Dr. Hayden is also Canada Research Chair in Human Genetics and Molecular Medicine. Hayden is best known for his research in Huntington disease (HD).
Stanley Howard Zlotkin, is a Canadian Professor of Paediatrics, Public Health Sciences and Nutritional Sciences at the University of Toronto.
Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.
Francis Allan Plummer was a Canadian scientist, academic and HIV/AIDS researcher. He was "a recognized specialist in infectious diseases whose work influenced public health policy in Canada and abroad". He was Distinguished Professor Emeritus of Medicine and Medical Microbiology at the University of Manitoba and Scientific Director General, National Microbiology Laboratory.
Éric A. Cohen is a Canadian molecular virologist whose research is focused on human immunodeficiency virus (HIV)-host interactions that govern viral replication and persistence.
B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.
Lewis Edward Kay, is a Canadian academic and biochemist known for his research in biochemistry and nuclear magnetic resonance spectroscopy for the studies of the structure and behaviour of proteins. He is a professor of molecular genetics, biochemistry and chemistry at the University of Toronto and Senior Scientist in Molecular Medicine at The Hospital for Sick Children.
Colleen M. Flood is the Dean of Queen's University Faculty of Law.
James (Jim) Woodgett is a British-born biologist and the Principal Investigator of an active research laboratory at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System, in Toronto, Ontario, Canada. He was the Koffler Director of Research at the Lunenfeld-Tanenbaum Research Institute from November 2005 to January 2021.
Nubia Muñoz is a Colombian medical scientist and epidemiologist, whose research has been instrumental in establishing that human papillomavirus (HPV) infection is the primary cause of cervical cancer which has led to the development of a vaccine that is capable of preventing 70% of all cervical cancers.